EVT — Eaton Vance Tax-Advantaged Dividend Income Fund
—
NYSE ·
Unknown ·
Unknown ·
CIK 1253327 ·
Last close
$27.00
Market Cap
$2.01B
52W High
$27.10
52W Low
$23.44
ADV30
91,973
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Oct 2025 | — | — | — | — | 2,467,957,147 | 331,204 | 468,491,415 |
| Apr 2025 | — | — | — | — | 2,253,903,995 | 25,883 | 451,099,176 |
| Oct 2024 | — | — | — | — | 2,412,411,209 | 254,852 | 451,748,853 |
Balance + Analyst (yfinance extras)
Retained Earnings
$573,340,236
Inventory
—
Receivables
$19,098,640
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$67,319,888
EBITDA
—
Free Cash Flow
$19,448,924
Enterprise Value
$2,430,252,288
Total Cash
$331,204
Total Debt
$447,000,000
Shares Out
74,542,782
Trailing EPS
$2.50
Book Value
$26.82
ROE
9.4%
ROA
1.2%
Div Yield
7.42%
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Oct 2025 | 187,421,060 | — | 186,040,279 | 2,467,957,147 | 468,491,415 | — | 147,313,255 |
| Oct 2024 | 495,203,953 | — | 493,849,490 | 2,412,411,209 | 451,748,853 | — | 141,502,759 |
| Oct 2023 | -32,078,516 | — | -33,442,800 | 2,059,696,352 | 451,535,463 | — | 136,295,170 |
| Oct 2022 | -209,389,790 | — | -210,670,466 | 2,228,171,780 | 453,464,499 | — | 117,489,595 |
| Oct 2021 | — | — | — | — | — | — | — |
News headlines (Yahoo Finance, 1h cache)
Kiplinger’s May 2026 Letter Says Yields From 3% to 13% Are Available Right Now Despite Iran War Uncertainty
2026-05-17 13:38 · Yahoo
Eaton Vance Closed-End Funds Release Estimated Sources of Distributions
2026-04-30 16:30 · Yahoo
Is It Time To Reassess Evotec (XTRA:EVT) After The Recent 24.5% Share Price Jump
2026-04-17 23:06 · Yahoo
Evotec (XTRA:EVT) Valuation Check After Recent Share Price Rebound
2026-04-17 09:05 · Yahoo
Evotec Appoints Dr. Ingrid Müller as Chief Operating Officer
2026-04-15 05:50 · Yahoo
Evotec Nominates Dieter Weinand as Supervisory Board Chairman
2026-04-07 07:00 · Yahoo
Evotec SE to Announce Fourth Quarter and Full-Year 2025 Results on April 8, 2026
2026-04-01 09:35 · Yahoo
Evotec Appoints Dr. Ashiq H. Khan as Chief Commercial Officer
2026-04-01 05:50 · Yahoo
Just - Evotec Biologics Enters Project Agreement with BARDA to Optimize Biomanufacturing of Antibodies Against Ebola and Related Viruses
2026-03-23 07:10 · Yahoo
Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation
2026-03-19 06:50 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.